Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
69.01
Oct 21 • 3:59 PM ET Dollar change-1.22 Percentage change(-1.74%)
Aftermarket Close
68.72
Aftermarket • 7:56 PM ET Dollar change-0.29 Percentage change(-0.42%)
Oct 20, 12:51 PMGE HealthCare launches global clinical evaluation program for StarGuide GX theranostics SPECT/CT with five leading institutions
Index
NDX, S&P 500
Market Cap
31.17B
Enterprise Value
39.85B
Income
1.99B
Sales
21.27B
Book/sh
24.30
Cash/sh
4.66
Employees
54000
IPO
Dec 15, 2022
P/E
15.86
Forward P/E
12.69
PEG
1.32
P/S
1.47
P/B
2.84
P/C
14.81
P/FCF
19.74
EV/EBITDA
11.29
EV/Sales
1.87
Quick Ratio
0.91
Current Ratio
1.21
Debt/Eq
0.96
LT Debt/Eq
0.95
Option/Short
Yes / Yes
EPS (ttm)
4.35
EPS next Y
5.44
EPS next Q
1.20
EPS this Y
7.24%
EPS next Y
10.44%
EPS next 5Y
9.60%
EPS past 3/5Y
2.53% 0.61%
Sales past 3/5Y
3.99% 3.74%
EPS Y/Y TTM
-11.06%
Sales Y/Y TTM
6.52%
EPS Q/Q
16.45%
Sales Q/Q
5.75%
Insider Own
0.32%
Insider Trans
7.73%
Inst Own
92.46%
Inst Trans
-1.35%
ROA
5.46%
ROE
19.19%
ROIC
9.28%
Gross Margin
39.37%
Oper. Margin
13.73%
Profit Margin
9.33%
SMA20
3.08%
SMA50
0.85%
SMA200
-1.79%
Trades
Shs Outstand
451.69M
Shs Float
450.24M
52W High
89.77 -23.13%
52W Low
58.75 17.46%
Volatility
2.12% 2.29%
ATR (14)
1.65
RSI (14)
56.69
Beta
0.84
Rel Volume
0.58
Avg Volume
3.77M
Volume
2,182,608
Perf Week
0.79%
Perf Month
4.13%
Perf Quarter
11.32%
Perf Half Y
-3.32%
Perf YTD
-15.86%
Perf Year
-9.32%
Perf 3Y
7.74%
Perf 5Y
-
Perf 10Y
-
Prev Close
70.23
Price
69.01
Change %
-1.74%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lobo KevinDirectorMay 22 '26Buy64.1810,000641,80014,363May 26 06:44 PM
Hochman Rodney FDirectorMay 12 '26Buy62.031,618100,3651,618May 13 04:19 PM
Yang Watkin Phoebe L.DirectorMay 08 '26Buy63.011,00063,00613,702May 11 08:16 PM
CULP H LAWRENCE JRDirectorMay 06 '26Buy61.8880,8055,000,076151,207May 07 04:14 PM
Stromberg William JDirectorMay 06 '26Buy61.691,00061,68915,330May 07 04:09 PM
SACCARO JAMESChief Financial OfficerMay 01 '26Buy60.603,310200,58587,471May 01 11:38 AM
Jimenez Frank RGC & Corporate SecretaryApr 30 '26Buy60.451,750105,78893,932Apr 30 04:21 PM
Arduini Peter JPresident and CEOApr 30 '26Buy59.924,169249,827259,424Apr 30 04:20 PM
Kenneth StacherskiFormer OfficerNov 24 '25Proposed Sale77.004,585353,045Nov 24 04:24 PM
Kenneth StacherskiFormer OfficerOct 27 '25Proposed Sale78.954,585361,993Oct 27 04:26 PM
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment provides scanning devices, clinical applications, service capabilities, and digital solutions. The AVS segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The PCS segment specializes in providing medical devices, consumables, services, and digital solutions. The PDx segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company was founded in 1892. It was incorporated on May 16, 2022 and is headquartered in Chicago, IL.
PresidentMr. Peter J. Arduini
M.S.Dr. Taha Kass-Hout M.D.
General Counsel & Corporate SecretaryMr. Frank R. Jimenez Esq.
President & CEO of Patient Care SolutionsMs. Jeannette Bankes
Chief Financial OfficerMr. William K. Grogan